APA (7th ed.) Citation

Lin, C., Chung, C., Chen, J., Chi, N., Hu, C., Huang, H., . . . Lee, H. (2026). Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine. Journal of Clinical Medicine, 15(13), 4963. https://doi.org/10.3390/jcm15134963

Chicago Style (17th ed.) Citation

Lin, Chun-Fu, et al. "Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine." Journal of Clinical Medicine 15, no. 13 (2026): 4963. https://doi.org/10.3390/jcm15134963.

MLA (9th ed.) Citation

Lin, Chun-Fu, et al. "Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine." Journal of Clinical Medicine, vol. 15, no. 13, 2026, p. 4963, https://doi.org/10.3390/jcm15134963.